Fig. 3From: CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinibKaplan-Meier plot of cumulative progression free survival (PFS) (a) nSD prior to treatment (median: 0.58) and (b) nSD following treatment (median: 0.56)Back to article page